The effects of trifluoperazine
become evident that Ca2+ dependence of many physiological processes is related to calmodulin (Cheung, 1980) . It has also been shown that calmodulin activates phosphorylase kinase of skeletal muscle (Walsh et al., 1980 Phosphorylase a assay
Phosphorylase a activity in the liver was determined using a method of Gilboe et al. (1972) Fig. 3) . Approximately the same range of concentration of trifluoperazine was also effective on vasopressin and angiotensin II. Effect of trifluoperazine on 45Ca2+ efflux Phenylephrine (Fig. 5A) or vasopressin (Fig. 5B) caused a rapid and transient increase in 45Ca2+ efflux from 45Ca2+ pre-loaded liver. Trifluoperazine significantly inhibited those effects of phenylephrine and vasopressin without changing the time course of 45Ca2+ efflux. As shown in Table 2 , the total amount of 45Ca2+ released following the administration of either phenylephrine, vasopressin or angioten- Liver was pre-perfused in a recirculating system with KRT buffer containing 1 mM 45CaCl2 for 45 min. Then the liver was perfused in a flow-through system, and trifuoperazine was added to the buffer when indicated. Fifteen min after the switch to a flow-through system, phenylephrine, vasopressin or angiotestsin II was added to the buffer. Radioactivity in each fraction was counted in a scintillation spectrometer. sin II was decreased significantly by trifluoperazine.
Effect of trifluoperazine on cyclic nucleotides level The effects of trifluoperazine on the tissue cyclic nucleotide level were studied to see whether the inhibitory effect of trifluoperazine is related to the change in tissue cyclic AMP or cyclic GMP levels. However, in the presence of 1 mM Ca2+, no significant changes in the 
Discussion
The present study clearly demonstrates that trifluoperazine specificially inhibits the activation of glycogenolysis by hormones which are believed to be dependent on Ca2+ ion for their actions, i.e. phenylephrine, vasopressin and angiotensin II. These results are different from those in isolated hepatocytes (Blackmore et al., 1981) . First, trifluoperazine significantly inhibited the effect of vasopressin. It is possible that the concentration of vasopressin they used (555 nM) was so high that chlorpromazine (10-6 M) could not inhibit the effect of vasopressin. In fact, the concentration of vasopressin they used is extremely high from the physiological range. As shown in Fig. 2 , the inhibitory effect of trifluoperazine was demonstrable only when the concentrations of vasopressin were relatively low (less than 1 nM). Alternatively, some properties of hepatocytes cannot necessarily be applied to physiological conditions. In the present system the modes of trifluoperazine action on phenylephrine or angiotensin II and on vasopressin are different, suggesting different sites of trifluoperazine action among these hormones. Since the effects of the drug on phosphorylase activation by glucagon and by phenylephrine are different, these sites appear to be located before the activation of phosphorylase. In addition, the present effect of the drug was not associated with a change in tissue cyclic AMP or cyclic GMP level and the drug elicited no effect on the activation of glycogenolysis by glucagon or cyclic AMP. Therefore, cyclic nucleotides-related process may not be involved. On the other hand, the effect of trifluoperazine was specific for all Ca2+-dependent hormones, and was associated with the inhibition of Ca2+ efflux induced by these hormones. Therefore, it is conceivable that the mechanism of trifluoperazine action is somehow related to the change in the Ca2+ flux or Ca2+-dependent process induced by these hormones, although it is still possible that the drug inhibits the binding of all these Ca2+-dependent hormones to their receptors. It is becoming evident that calmodulin modulates the movement of Ca2+ within the cell or across plasma membranes. For example, calmodulin activates (Ca2+-Mg2+)-dependent ATPase of erythrocytes (Janet and Penninston, 1970; Gopinath and Vincenzi, 1977) and fat cells (Pershadsingh et al., 1980) . Trifluoperazine significantly inhibits the activation of Ca2+ efflux as well as thyrotropin secretion from pituitary by TRH or depolarization (Fleckman et al., 1981) . These observations support the concept that the blockade of calmodulin action may result in an inhibition of hormone-induced Ca2+ mobilization from the cells, as was observed in the present study. Moreover, it is shown that 1) Skeletal muscle contains Ca2+-and calmodulin-dependent protein kinase which activates phosphorylase kinase (Waisman et al., 1978) ; 2) Phosphorylase kinase of skeletal muscle contains calmodu-lin as its subunit (Cohen et al., 1978) ; 3) Hepatic phosphorylase kinase is also Ca2+ stimulatable (Khoo and Steinberg, 1975; Assimacopoulos-Jeannet et al., 1977) . In view of the possible involvement of calmodulin in these processes and the specific effect of trifluoperazine on all Ca2+-dependent hormones, the possibility that phenothiazine drugs interact with calmodulin in vivo in liver still remains open. Therefore, it seems too early to conclude that these drugs act solely as an
